Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancerAmritha Nair, Thomas F. Westbrook, Jin‐Peng Sun et al.|Nature Medicine|2018Cited by 83
Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast CancerNicholas J. Neill, Charles M. Perou, Shankha Satpathy et al.|Cancer Discovery|2025Cited by 3
Data from Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast CancerNicholas J. Neill, Charles M. Perou, Shankha Satpathy et al.|Unknown|2025Cited by 0
Figure S2 from Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast CancerNicholas J. Neill, Charles M. Perou, Shankha Satpathy et al.|Unknown|2025Cited by 0
Figure S3 from Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast CancerNicholas J. Neill, Charles M. Perou, Shankha Satpathy et al.|Unknown|2025Cited by 0